The Office of Naval Research is sponsoring the development of a portable, three-part system that can measure blast pressure, establish injury thresholds for the brain and analyze potential traumatic brain injury symptoms. It's called Blast Load Assessment Sense and Test--BLAST, for short.
A father and son team have created a liquid metal 3-D printing machine that could represent a significant transformation in manufacturing. The machine is so novel it represents a quantum leap in the ability to print three-dimensional objects in metal. Other metal printers exist, but most use a process of laying down powered metal and melting it with a laser or electron beam.
In a letter released today by UsAgainstAlzheimer's, Co-Founder and Chairman George Vradenburg said the negative clinical trial of a once-promising Alzheimer's drug, Solanezumab, which showed clinically insignificant ability to slow cognitive decline in Alzheimer's patients, should be viewed not as a failure, but as a development that 'provides valuable lessons and suggests a way forward in the fight against Alzheimer's.'
The Endocrine Society unveiled the first issue of its open-access scholarly publication the Journal of the Endocrine Society today, marking the first time the society has introduced a new journal under its ownership in nearly 30 years.
Researchers study the ways in which moss can survive in hostile environments.
Children's National Health System and Inova this week announced a new three-year, $2.8 million research and education collaboration in maternal, fetal and neonatal medicine that aims to leverage the strengths of both health care facilities to improve the health of pregnant women and their children.
Entering a 'wheat pan-genomics' era from single to multiple wheat DNA references, the Earlham Institute aims to diversify one of the world's most complex genomes to improve yield quality and increase wider production of this critical food crop.
With Chagas disease becoming more prevalent in the United States, a diagnostic to quickly and easily detect infection is needed. Today, IDRI (Infectious Disease Research Institute) announces that a fusion antigen it developed and patented is being used as part of a Chagas disease diagnostic test created by InBios and recently approved by the US Food & Drug Administration (FDA) for use in the United States. This marks the first point-of-care diagnostic test for Chagas disease available in the United States.
Collaboration will investigate the efficacy of a system biology approach to identifying treatment options for patients with advanced gastrointestinal stromal tumors.
The partnership aims to advance oral health through community-based research, education, and patient care.